Meredith M. HoogFollowEli Lilly (United States)1 paperORCID 0009-0000-1954-847X ↗OpenAlex ↗PapersJournal of Managed Care & Specialty PharmacyHumans·30 SepReal-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes
Journal of Managed Care & Specialty PharmacyHumans·30 SepReal-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes